减重护理市场规模、份额和成长分析（按程序类型、药物类型、最终用户和地区）- 行业预测，2025-2032 年

2023年全球肥胖治疗市场规模预计为93.9亿美元，预计将从2024年的97.0亿美元增长到2032年的125.8亿美元，预测期内（2025-2032年）的复合年增长率为3.3%。

由于肥胖症的盛行率不断上升以及糖尿病、心血管疾病和某些癌症等相关健康风险，全球肥胖症治疗市场正在快速成长。这种快速增长主要是由于久坐的生活方式、不良的饮食习惯和遗传因素造成的。因此，迫切需要有效的肥胖症治疗方法。该市场的关键参与者包括提供已通过核准的药物的製药公司，这些药物透过抑制食慾或增加能量消耗来帮助减肥。此外，减重手术等外科手术选择和胃内水球等医疗设备也有助于增强体重管理效果。生活方式的改变也扮演着重要角色。这个充满活力的产业为医疗保健相关人员之间的创新、投资和合作提供了重要机会，以有效对抗肥胖症流行。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

肥胖治疗市场规模（按手术类型和复合年增长率） (2025-2032)

• 市场概况
• 胆胰分流术及十二指肠转位术 (BPD/DS)
• 胃束带手术调整
• 胃绕道手术手术
• 袖状切除术
• 内视镜手术

肥胖治疗市场规模：药物类型与复合年增长率（2025-2032）

• 市场概况
• 食慾抑制剂
• 伴随用药
• 吸收不良
• 饱腹药水

肥胖治疗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊所
• 美容机构
• 其他的

肥胖治疗市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Novo Nordisk（Denmark）
• Eli Lilly and Company（United States）
• Roche（Switzerland）
• GlaxoSmithKline（GSK）（United Kingdom）
• AstraZeneca（United Kingdom）
• Johnson & Johnson（United States）
• Sanofi（France）
• Pfizer（United States）
• Amgen（United States）
• Boehringer Ingelheim（Germany）
• Medtronic（Ireland）
• Altimmune（United States）
• Viking Therapeutics（United States）
• Structure Therapeutics（United States）
• NovoCure（United States）
• Arena Pharmaceuticals（United States）
• Rhythm Pharmaceuticals（United States）
• Zafgen（United States）
• Vivus（United States）

结论和建议

Global Obesity Treatment Market size was valued at USD 9.39 billion in 2023 and is poised to grow from USD 9.7 billion in 2024 to USD 12.58 billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The global obesity treatment market is experiencing rapid growth due to the escalating prevalence of obesity and its associated health risks including diabetes, cardiovascular diseases, and specific cancers. This surge is largely attributed to sedentary lifestyles, poor dietary choices, and genetic factors. As a result, there's an urgent demand for effective obesity interventions. Key players in this market include pharmaceutical companies offering approved medications that aid weight loss by suppressing appetite or enhancing energy expenditure. Additionally, surgical options like bariatric surgery and medical devices such as gastric balloons enhance weight management efforts. Lifestyle modifications play a crucial role as well. This dynamic sector presents substantial opportunities for innovation, investment, and collaboration among healthcare stakeholders to combat the obesity epidemic effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Obesity Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Obesity Treatment Market Segmental Analysis

Global Obesity Treatment Market is segmented by Surgery Type, Drug Type, End User and region. Based on Surgery Type, the market is segmented into Biliopancreatic diversion with Duodenal Switch (BPD/DS), Adjusting Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy and Endoscopic Procedures. Based on Drug Type, the market is segmented into Appetite suppressants, Combination drugs, Malabsorption and Satiety drugs. Based on End User, the market is segmented into Hospital, Clinics, Beauty institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Obesity Treatment Market

The global obesity treatment market is significantly propelled by the alarming increase in obesity rates worldwide. Contributing factors include sedentary lifestyles, poor dietary choices, and genetic tendencies, all of which have intensified this public health crisis. As the prevalence of obesity continues to rise, so does the urgency for effective treatment options aimed at mitigating the associated health risks. This pressing need is fostering a greater demand for innovative obesity treatment solutions, pushing the market forward and creating opportunities for new therapies and programs that can effectively combat this escalating issue.

Restraints in the Global Obesity Treatment Market

The Global Obesity Treatment market faces significant restraints due to the limited or sometimes nonexistent insurance coverage for obesity-related therapies. Many insurance providers impose strict eligibility criteria for coverage, such as requiring individuals to meet specific Body Mass Index (BMI) thresholds or to prove unsuccessful attempts at previous weight loss methods. This restrictive insurance landscape can severely limit access to essential treatments, leading to challenges in managing obesity effectively. As a result, individuals may struggle to obtain the care they need, undermining efforts to combat obesity on a broader scale and potentially reducing the overall success rates of treatment programs.

Market Trends of the Global Obesity Treatment Market

The Global Obesity Treatment market is witnessing a significant trend towards personalized medicine, driven by the recognition of obesity as a multifaceted condition influenced by genetic and metabolic variations. Recent advancements in genomic research and biomarker identification are facilitating the creation of tailored therapies that align with individual patient profiles. This shift not only enhances the efficacy of treatments but also encourages patient adherence, setting the stage for a new wave of precision medications and targeted interventions. As healthcare providers increasingly embrace this customized approach, the market is poised for growth, underscoring the importance of understanding individual differences in obesity management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Obesity Treatment Market Size by Surgery Type & CAGR (2025-2032)

• Market Overview
• Biliopancreatic diversion with Duodenal Switch (BPD/DS)
• Adjusting Gastric Banding
• Roux-en-Y Gastric Bypass
• Sleeve gastrectomy
• Endoscopic Procedures

Global Obesity Treatment Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Appetite suppressants
• Combination drugs
• Malabsorption
• Satiety drugs

Global Obesity Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Beauty institutions
• Others

Global Obesity Treatment Market Size & CAGR (2025-2032)

• North America (Surgery Type, Drug Type, End User)
  • US
  • Canada
• Europe (Surgery Type, Drug Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Surgery Type, Drug Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Surgery Type, Drug Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Surgery Type, Drug Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viking Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Structure Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovoCure (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arena Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rhythm Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zafgen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations